Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
Feb. 15, 2017 Blumenthal Statement on the Withdrawn Nomination of Andrew Puzder Sen. Richard Blumenthal Washington, DC
Feb. 15, 2017 New Food Date Labels a Positive First Step, Blumenthal Announces Intent to Reintroduce Commonsense Food Date Labeling Bill Sen. Richard Blumenthal Washington, DC
Feb. 15, 2017 Senator Coons Introduces Bipartisan, Bicameral Legislation to Establish U.S. Chief Manufacturing Officer Position Sen. Christopher Coons Washington, DC
Feb. 15, 2017 Scott Statement on Andrew Puzder Rep. Robert Scott Washington, DC
Feb. 15, 2017 Collins, King, Pingree and Poliquin Applaud ITC's Unanimous Final Decision, Ruling in Favor of Auburn Manufacturing and Against Illegal Chinese Trade Sen. Susan Collins Washington, DC
Feb. 15, 2017 Democratic Health Leaders Blast Proposed CMS Marketplace Rule Rep. Robert Scott Washington, DC
Feb. 14, 2017 Maria Pagan, Acting United States Trade Ambassador - Maine Delegation Urges U.S. Trade Representative to Ensure Canada is Adhering to Trade Rules and to Guard Against Potentially Illegal and Harmful Subsidies Sen. Susan Collins Washington, DC
Feb. 14, 2017 Maria Pagan, Acting United States Trade Ambassador - Maine Delegation Urges U.S. Trade Representative to Ensure Canada is Adhering to Trade Rules and to Guard Against Potentially Illegal and Harmful Subsidies Sen. Angus King Washington, DC
Feb. 14, 2017 Hearing of the Digital Commerce and Consumer Protection Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Self-Driving Cars: Road to Deployment Rep. Greg Walden Washington, DC
Feb. 14, 2017 Maria Pagan, Acting United States Trade Ambassador - Maine Delegation Urges U.S. Trade Representative to Ensure Canada is Adhering to Trade Rules and to Guard Against Potentially Illegal and Harmful Subsidies Rep. Chellie Pingree Washington, DC
Feb. 14, 2017 Maria Pagan, Acting United States Trade Ambassador - Maine Delegation Urges U.S. Trade Representative to Ensure Canada is Adhering to Trade Rules and to Guard Against Potentially Illegal and Harmful Subsidies Rep. Bruce Poliquin Washington, DC
Feb. 14, 2017 Murphy Votes for Linda McMahon as Head of Small Business Administration Sen. Christopher Murphy Washington, DC
Feb. 14, 2017 Blumenthal Votes for McMahon as SBA Administrator Sen. Richard Blumenthal Washington, DC
Feb. 14, 2017 Hearing of the Digital Commerce and Consumer Protection Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Latta, Hearing on Self-Driving Cars: Road to Deployment Rep. Robert Latta Washington, DC
Feb. 14, 2017 Hearing of the Health, Employment, Labor, and Pensions Subcommittee of the House Education and Workforce Committee - Opening Statement by Rep. Walberg, Hearing on Restoring Balance and Fairness to the National Labor Relations Board Rep. Timothy Walberg Washington, DC
Feb. 14, 2017 Witnesses Describe Urgent Need to Restore Balance & Fairness to NLRB Rep. Timothy Walberg Washington, DC
Feb. 14, 2017 Los Angeles Times - More Government May Not be the Answer to Boosting Retirement Savings Rep. Timothy Walberg Unknown
Feb. 14, 2017 Gardner Votes to Confirm Linda McMahon to Head the Small Business Administration Sen. Cory Gardner Washington, DC
Feb. 13, 2017 Murphy Votes Against Confirming Steven Mnuchin as Treasury Secretary Sen. Christopher Murphy Washington, DC
Feb. 13, 2017 Ahead of Valentine's Day, Murphy Calls on Usda to Support U.s. Floral Industry & American-grown Flowers Sen. Christopher Murphy Washington, DC
Feb. 13, 2017 Murphy Highlights Middlefield Manufacturer, Cooper-Atkins, as "Murphy's Monday Manufacturer" Sen. Christopher Murphy Hartford, CT
Feb. 13, 2017 Letter to Michael Young, Acting Deputy Secretary of the Department of Agriculture - Ask For Continued Support of the American Horticulture Industry Sen. Christopher Murphy Washington, DC
Feb. 13, 2017 Hoeven Delivers Congressional Response to 2017 State of Indian Nations Address Sen. John Hoeven Washington, DC
Feb. 10, 2017 Latta on Designation of Commissioner Ann Marie Buerkle as Acting Chairman of CPSC Rep. Robert Latta Washington, DC
Feb. 9, 2017 Sen. Franken Introduces Measure to End Exclusive Stock Deals for Members of Congress Sen. Al Franken Unknown
Feb. 9, 2017 Senators Coons and Gardner Introduce Bipartisan Bill to Help Small Manufacturers Access Affordable Loans Sen. Christopher Coons Washington, DC
Feb. 9, 2017 Senators Coons and Gardner Introduce Bipartisan Bill to Help Small Manufacturers Access Affordable Loans Sen. Cory Gardner Washington, DC
Feb. 9, 2017 Help Small Manufacturers Access Affordable Loans Sen. Cory Gardner Washington, DC
Feb. 9, 2017 Help Small Manufacturers Access Affordable Loans Sen. Christopher Coons Washington, DC
Feb. 8, 2017 Collins, King Welcome Sappi Fine North America Announcement of $165 million Investment in its Somerset Mill in Skowhegan Sen. Angus King Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Al Franken Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Amy Klobuchar Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Margaret Wood Hassan Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Sheldon Whitehouse Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Maria Cantwell Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Christopher Murphy Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Mark Warner Washington, DC
Feb. 8, 2017 Self-driving cars are the next frontier of innovation and safety Rep. Frederick Upton unknown
Feb. 8, 2017 Blumenthal, Murphy Demand Answers About Outrageous Price Hike for Lifesaving Anti-opioid Drug Sen. Christopher Murphy Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Thomas Udall Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Debbie Stabenow Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Kirsten Gillibrand Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Bernard Sanders Washington, DC
Feb. 8, 2017 Collins, King Welcome Sappi Fine North America Announcement of $165 million Investment in its Somerset Mill in Skowhegan Sen. Susan Collins Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Tammy Baldwin Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Jon Tester Washington, DC
Feb. 8, 2017 Self-driving cars are the next frontier of innovation and safety Sen. Gary Peters unknown
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Claire McCaskill Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Richard Durbin Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Jeffery Merkley Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Patrick Leahy Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Elizabeth Warren Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Angus King Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Richard Blumenthal Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Jeanne Shaheen Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Tammy Duckworth Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Heidi Heitkamp Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Dianne Feinstein Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. John Reed Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Gary Peters Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Cory Booker Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Joe Donnelly Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Timothy Kaine Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Sherrod Brown Washington, DC
Feb. 8, 2017 Letter to Mr. Spencer Williamson, President and Chief Executive Officer of Kaléo Pharmaceuticals - Concern That Kaléo Dramatically Increased the Cost of its Naloxone Injector Device Sen. Edward Markey Washington, DC
Feb. 7, 2017 Murray Statement on Status of Puzder Nomination Sen. Patty Murray Washington, DC
Feb. 7, 2017 Sen. Franken Joins Senate Colleagues, Entrepreneurs, Advocates, Consumers to Defend Net Neutrality Sen. Al Franken Unknown
Feb. 6, 2017 Murphy Highlights Middletown Manufacturer, EB Manufacturing, as "Murphy's Monday Manufacturer" Sen. Christopher Murphy Hartford, CT
Feb. 3, 2017 Rubio Renews Support for Bipartisan Bill to Protect Florida Cigar Workers' Jobs Sen. Marco Rubio Washington, DC
Feb. 3, 2017 A Pro-Growth Budget is Needed to Help Americans Succeed Rep. Diane Black Washington, DC
Feb. 3, 2017 Eshoo Statement on President Trump's Supreme Court Nomination Rep. Anna Eshoo Unknown
Feb. 3, 2017 Letter to the President - Support the Bureau of Labor Statistics Data Rep. Robert Scott Washington, DC
Feb. 2, 2017 Schatz To Oppose Efforts To Roll Back Anti-Corruption Law Sen. Brian Schatz Washington, DC
Feb. 2, 2017 Hearing of the House Budget Committee - Opening Statement by Rep. Black, Hearing on CBO's Budget and Economic Outlook Rep. Diane Black Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Debbie Stabenow Washington, DC
Feb. 1, 2017 Bipartisan, Bicameral Letter Encourages Pres. Trump to Support Key Manufacturing Council Recommendations Sen. Christopher Coons Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Claire McCaskill Washington, DC
Feb. 1, 2017 Bipartisan, Bicameral Letter Encourages Pres. Trump to Support Key Manufacturing Council Recommendations Rep. Thomas Reed Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Ron Wyden Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Robert Casey Washington, DC
Feb. 1, 2017 Bipartisan, Bicameral Letter Encourages Pres. Trump to Support Key Manufacturing Council Recommendations Rep. Timothy Ryan Washington, DC
Feb. 1, 2017 Gardner Joins Bill in Support of Colorado Craft Brewers Sen. Cory Gardner Unknown
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Benjamin Cardin Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Mark Warner Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Sherrod Brown Washington, DC
Feb. 1, 2017 Hearing of the Energy Subcommittee of the House Energy and Commerce Committee - Opening Statement by Rep. Walden, Hearing on the Electricity Sector's Efforts to Respond to Cybersecurity Threats Rep. Greg Walden Washington, DC
Feb. 1, 2017 Bipartisan, Bicameral Letter Encourages Pres. Trump to Support Key Manufacturing Council Recommendations Sen. Jerry Moran Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Thomas Carper Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Robert Menendez Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Maria Cantwell Washington, DC
Feb. 1, 2017 Hearing of the Senate Commerce, Science, and Transportation Committee - Opening Statement of Sen. Bill Nelson, Hearing on A Growth Agenda: Reducing Unnecessary Regulatory Burdens Sen. William Nelson Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. Michael Bennet Washington, DC
Feb. 1, 2017 Letter to the Hon. Orin Hatch - Regarding Call for Price and Mnuchin to Come Clean on Ethical Ties, Business Practices Sen. William Nelson Washington, DC
Jan. 31, 2017 Letter to the President - Urging to Include Broadband in any Infrastructure Initiative Sen. Richard Durbin Washington, DC
Jan. 31, 2017 Letter to Donald Trump, President - Expression of Support for the Recent Announcement of Your Manufacturing Jobs Initiative and Your Intent to Seek Counsel from CEOs and Business Leaders Sen. Christopher Coons Washington, DC
Jan. 31, 2017 Letter to the President - Urging to Include Broadband in any Infrastructure Initiative Sen. Gary Peters Washington, DC
Jan. 31, 2017 New Report from Senators Murray, Warren: Workers Under Andrew Puzder Are Overworked, Underpaid, and Lack Basic Benefits Sen. Patty Murray Washington, DC
Jan. 31, 2017 Letter to the President - Urging to Include Broadband in any Infrastructure Initiative Sen. Ron Wyden Washington, DC
Jan. 31, 2017 Letter to the President - Urging to Include Broadband in any Infrastructure Initiative Sen. Patty Murray Washington, DC
Jan. 31, 2017 Letter to the President - Urging to Include Broadband in any Infrastructure Initiative Sen. Margaret Wood Hassan Washington, DC
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top